The contribution of biological, mathematical, clinical, engineering and social sciences to combatting the West African Ebola epidemic

The tragic West African Ebola epidemic claimed many lives, but would have been worse still if scientific insights from many disciplines had not been integrated to create a strong technical response. Epidemiology and modelling triggered the international response and guided where response efforts were directed; virology, engineering and clinical science helped reduce deaths and transmission in and from hospitals and treatment centres; social sciences were key to reducing deaths from funerals and in the community; diagnostic and operational research made the response more efficient; immunology and vaccine research contributed to the final stages of the epidemic and will help prevent future epidemics. These varied scientific contributions had to be integrated into a combined narrative, communicated to policymakers to inform decisions, and used by courageous local and international responders in the field in real time. Not every area of science was optimal, and in particular, clinical trials of simple interventions such as fluid management were slow to be adopted and sharing of data was initially poor. This Ebola epidemic demonstrated how science can respond to a major emergency, but also has lessons for better responses in future infectious emergencies. This article is part of the themed issue ‘The 2013–2016 West African Ebola epidemic: data, decision-making and disease control’.

[1]  A. Chughtai,et al.  Persistence of Ebola virus in various body fluids during convalescence: evidence and implications for disease transmission and control , 2016, Epidemiology and Infection.

[2]  Christl A. Donnelly,et al.  The role of rapid diagnostics in managing Ebola epidemics , 2015, Nature.

[3]  W. Team Ebola Virus Disease in West Africa — The First 9 Months of the Epidemic and Forward Projections , 2014 .

[4]  James Fairhead,et al.  The significance of death, funerals and the after-life in Ebola-hit Sierra Leone, Guinea and Liberia: Anthropological insights into infection and social resistance , 2014 .

[5]  R. Davey,et al.  Clinical Management of Ebola Virus Disease in the United States and Europe. , 2016, The New England journal of medicine.

[6]  M. J. Broadhurst,et al.  ReEBOV Antigen Rapid Test kit for point-of-care and laboratory-based testing for Ebola virus disease: a field validation study , 2015, The Lancet.

[7]  Mikiko Senga,et al.  Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections. , 2014, The New England journal of medicine.

[8]  Paul Richards,et al.  Social Pathways for Ebola Virus Disease in Rural Sierra Leone, and Some Implications for Containment , 2015, PLoS neglected tropical diseases.

[9]  J. Farrar,et al.  The Ebola Vaccine Team B: a model for promoting the rapid development of medical countermeasures for emerging infectious disease threats , 2015, The Lancet Infectious Diseases.

[10]  M. Meltzer,et al.  Preventive malaria treatment for contacts of patients with Ebola virus disease in the context of the west Africa 2014-15 Ebola virus disease response: an economic analysis. , 2016, The Lancet. Infectious diseases.

[11]  Paul Richards,et al.  Ebola: limitations of correcting misinformation , 2015, The Lancet.

[12]  M. Meltzer,et al.  Estimating the future number of cases in the Ebola epidemic--Liberia and Sierra Leone, 2014-2015. , 2014, MMWR supplements.

[13]  Neil Ferguson,et al.  Infectious disease: Tough choices to reduce Ebola transmission , 2014, Nature.

[14]  Anne M Johnson,et al.  Role of healthcare workers in early epidemic spread of Ebola: policy implications of prophylactic compared to reactive vaccination policy in outbreak prevention and control , 2015, BMC Medicine.

[15]  Adam Kucharski,et al.  Temporal Changes in Ebola Transmission in Sierra Leone and Implications for Control Requirements: a Real-time Modelling Study , 2015, PLoS currents.